PSTV
Plus Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$21.75M
P/E Ratio
—
EPS
$-7.25
Beta
1.02
52W High
$30.50
52W Low
$2.90
50-Day MA
$6.41
200-Day MA
$11.39
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.97
PEG Ratio
2.45
About Plus Therapeutics Inc
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing, and commercialization of treatments for patients with cancer and other diseases. The company is headquartered in Austin, Texas.
Fundamentals
| Revenue (TTM) | $5.21M |
| Gross Profit (TTM) | $-3.17M |
| EBITDA | $-14.85M |
| Operating Margin | -420.00% |
| Return on Equity | -522.00% |
| Return on Assets | -83.30% |
| Revenue/Share (TTM) | $1.68 |
| Book Value | $0.72 |
| Price-to-Book | 6.13 |
| Price-to-Sales (TTM) | 4.17 |
| EV/Revenue | 18.19 |
| EV/EBITDA | 29.14 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -3.20% |
| Shares Outstanding | $6.86M |
| Float | $6.34M |
| % Insiders | 1.45% |
| % Institutions | 14.02% |
Analyst Ratings
Consensus ($140.50 target)
1
Strong Buy3
Buy1
HoldData last updated: 4/9/2026